Literature DB >> 21723985

GLP-1-based therapies: the dilemma of uncertainty.

Joachim Spranger, Ursula Gundert-Remy, Thomas Stammschulte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723985     DOI: 10.1053/j.gastro.2011.05.019

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  17 in total

1.  Incretin-based therapies: facing the realities of benefits versus side effects.

Authors:  Harold E Lebovitz
Journal:  Diabetes Technol Ther       Date:  2013-10-10       Impact factor: 6.118

2.  Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling.

Authors:  Bendong Chen; Wenyan Zhou; Wenchao Zhao; Peng Yuan; Chaofeng Tang; Genwang Wang; Junzhi Leng; Jinlong Ma; Xiaowen Wang; Yongfeng Hui; Qi Wang
Journal:  Oncol Lett       Date:  2019-06-19       Impact factor: 2.967

Review 3.  Pancreatic Cancer and Diabetes Mellitus.

Authors:  Ayush Sharma; Suresh T Chari
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 4.  The treatment of type 2 diabetes.

Authors:  Andreas F H Pfeiffer; Harald H Klein
Journal:  Dtsch Arztebl Int       Date:  2014-01-31       Impact factor: 5.594

Review 5.  Diabetes medications and cancer risk: review of the literature.

Authors:  Quang T Nguyen; Lindsay Sanders; Anu P Michael; Scott R Anderson; Loida D Nguyen; Zackary A Johnson
Journal:  Am Health Drug Benefits       Date:  2012-07

Review 6.  Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.

Authors:  Ye Liu; Rui Wei; Tian-Pei Hong
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 7.  Regulation of glucose homeostasis by GLP-1.

Authors:  Prashant Nadkarni; Oleg G Chepurny; George G Holz
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

8.  The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients.

Authors:  Zeynel Abidin Sayiner; Gamze Inan Demiroğlu; Ersin Akarsu; Mustafa Araz
Journal:  Turk J Pharm Sci       Date:  2020-02-19

9.  Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Juyoung Shin; Jin-Sun Chang; Hun-Sung Kim; Sun-Hee Ko; Bong-Yun Cha; Ho-Young Son; Kun-Ho Yoon; Jae-Hyoung Cho
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

10.  Increased risk of acute pancreatitis in patients with type 2 diabetes: an observational study using a Japanese hospital database.

Authors:  Hisashi Urushihara; Masanori Taketsuna; Ying Liu; Eisei Oda; Masaki Nakamura; Shinichi Nishiuma; Rei Maeda
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.